Table 4.
No. of sites with pain | B (CI) | P |
---|---|---|
IL-8 | ||
(Intercept) | −1.14 (−2.19 to 0.08) | 0.036 |
Sex | 1.06 (0.5 to 1.6) | <0.001 |
Age | 0 (−0.01 to 0) | 0.399 |
BMI | 0.01 (−0.0to 0.03) | 0.177 |
Anxiety | 0.02 (0.02 to 0.05) | 0.432 |
Depression | 0 (−0.03 to 0.04) | 0.890 |
Fatigue | 0.06 (0.03 to 0.08) | <0.001 |
Stress | 0 (−0.02 to 0.03) | 0.909 |
Pain intensity | 0.03 (−0.3 to 0.09) | 0.355 |
IL-8 | 1.44 (0.09 to 2.78) | 0.036 |
Sex * IL-8 | −1.30 (−2.14 to 0.45) | 0.003 |
GM-CSF | ||
(Intercept) | 0.31 (−0.58 to 1.20) | 0.493 |
Sex | 0.34 (0.12 to 0.57) | 0.004 |
Age | 0 (−0.01 to 0) | 0.283 |
BMI | 0.01 (−0.01 to 0.03) | 0.274 |
Anxiety | 0 (−0.04 to 0.04) | 0.961 |
Depression | 0.01 (−0.03 to 0.05) | 0.586 |
Fatigue | 0.05 (0.02 to 0.08) | <0.001 |
Stress | 0.01 (−0.01 to 0.04) | 0.610 |
Pain intensity | 0.02 (−0.04 to 0.08) | 0.460 |
GM-CSF | −0.36 (−0.70 to 0.02) | 0.039 |
Means, 95% confidence intervals and p-values for the models including IL-8 and GM-CSF presented. The estimates represent the change in relation to log-transformed values of the cytokine analysis.